(Q28579124)

English

A novel endogenous erythropoietin mediated pathway prevents axonal degeneration

scientific journal article

In more languages

edit

Statements

1 reference

31 January 2017

A novel endogenous erythropoietin mediated pathway prevents axonal degeneration (English)

1 reference

31 January 2017

1 reference

Sanjay C. Keswani

1

1 reference

31 January 2017

Ulas Buldanlioglu

series ordinal

2

1 reference

31 January 2017

Angela Fischer

series ordinal

3

1 reference

31 January 2017

Nicole Reed

series ordinal

4

1 reference

31 January 2017

Michelle Polley

series ordinal

5

1 reference

31 January 2017

Hong Liang

series ordinal

6

1 reference

31 January 2017

Chunhua Zhou

series ordinal

7

1 reference

31 January 2017

Christelene Jack

series ordinal

8

1 reference

31 January 2017

Gerhard J. Leitz

series ordinal

9

1 reference

31 January 2017

Ahmet Hoke

series ordinal

10

1 reference

31 January 2017

1 December 2004

1 reference

31 January 2017

1 reference

31 January 2017

56

1 reference

31 January 2017

6

1 reference

31 January 2017

815–826

1 reference

31 January 2017

The axonopathy of diabetic neuropathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FANA.20285

retrieved

21 January 2018

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Juvenile and adult rat neuromuscular junctions: density, distribution, and morphology

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Axon pathology in neurological disease: a neglected therapeutic target

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Expression of cytokines, neurotrophins, neurotrophin receptors and NOS mRNA in dorsal root ganglion of a rat tourniquet model

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin and erythropoietin receptor in the developing human central nervous system

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin gene expression in different areas of the developing human central nervous system.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Immunohistochemical localization of erythropoietin and its receptor in the developing human brain.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Efficient analysis of experimental observations.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Axonal self-destruction and neurodegeneration

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

HIV-associated sensory neuropathies.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Neuronal-NOS adaptor protein expression after spreading depression: implications for NO production and ischemic tolerance

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin strikes a new cord

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

HIV neuropathy: insights in the pathology of HIV peripheral nerve disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Very early activation of m-calpain in peripheral nerve during Wallerian degeneration

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Differences in peripheral nerve degeneration/regeneration between wild-type and neuronal nitric oxide synthase knockout mice.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

FK506 is neuroprotective in a model of antiretroviral toxic neuropathy.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Provoking neuroprotection by peroxynitrite.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Early degeneration and sprouting at the rat neuromuscular junction following acrylamide administration

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Redefining toxic distal axonopathies

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.20285

Identifiers

1 reference

31 January 2017

release_etg66fqwljcwzp7cjjjezij6le

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/etg66fqwljcwzp7cjjjezij6le

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

31 January 2017

ResearchGate publication ID

8244508

0 references

(Q28579124)

A novel endogenous erythropoietin mediated pathway prevents axonal degeneration

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)